Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us nowThis statistic shows Abbott Laboratories' revenue of the Diagnostics segment from 2020 to 2023, broken down by category. In 2023, the Rapid Diagnostics category within this segment generated approximately 3.7 billion U.S. dollars, a significant decrease from the preceding year. The extraordinary growth witnessed in this segment was in large part an increased demand for COVID-19 tests since the beginning of the pandemic.
You only have access to basic statistics.
Business Solutions including all features.
Market overview
Key company data
Business distribution
Competitors
Further related statistics